| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jonathon C Arnold, Cassandra V Occelli Hanbury-Brown, Lyndsey L Anderson, Miguel A Bedoya-Pérez, Michael Udoh, Laura A Sharman, Joel S Raymond, Peter T Doohan, Adam Ametovski, Iain S McGrego. A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2024-11-11. PMID:39528623. |
cannabis contains the major cannabinoids, Δ |
2024-11-11 |
2024-11-17 |
rat |
| Júlia Dalfovo Marquez, Talissa Dezanetti, Roger Walz, Cristiane Ribeiro de Carvalh. Cannabinoid for alcohol use disorder. International review of neurobiology. vol 178. 2024-11-10. PMID:39523058. |
moreover, growing evidence has been proposed that cannabis or cannabinoid compounds may be helpful to treat alcohol use disorder (aud). |
2024-11-10 |
2024-11-17 |
Not clear |
| Júlia Dalfovo Marquez, Talissa Dezanetti, Roger Walz, Cristiane Ribeiro de Carvalh. Cannabinoid for alcohol use disorder. International review of neurobiology. vol 178. 2024-11-10. PMID:39523058. |
considering that advances in the legalization and decriminalization movements regarding cannabis have led to increased availability worldwide, the current chapter aims to provide evidence on the benefits and risks of combining alcohol and cannabis, as well as the potential therapeutic use of cannabinoid compounds in treating aud. |
2024-11-10 |
2024-11-17 |
Not clear |
| Ethan B Russo, Venetia L Whitele. Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure. Frontiers in toxicology. vol 6. 2024-11-07. PMID:39507417. |
cannabinoid hyperemesis syndrome presents as a complex of symptoms and signs encompassing nausea, vomiting, abdominal pain, and hot water bathing behavior, most typically in a heavy cannabis user. |
2024-11-07 |
2024-11-09 |
Not clear |
| Ethan B Russo, Venetia L Whitele. Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure. Frontiers in toxicology. vol 6. 2024-11-07. PMID:39507417. |
the syndrome is associated with escalating intake of high potency cannabis, or alternatively, other agonists of the cannabinoid-1 receptor including synthetic cannabinoids. |
2024-11-07 |
2024-11-09 |
Not clear |
| Ethan B Russo, Venetia L Whitele. Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure. Frontiers in toxicology. vol 6. 2024-11-07. PMID:39507417. |
the possible utilization of non-intoxicating antiemetic cannabis components in cannabis for treatment of cannabinoid hyperemesis syndrome is addressed, along with future research suggestions in relation to its genetic foundation and possible metabolomic signatures. |
2024-11-07 |
2024-11-09 |
Not clear |
| Nicholas C Glodosky, Michael J Cleveland, Reza Rahimi Azghan, Hassan Ghasemzadeh, Ryan J McLaughlin, Carrie Cuttle. Multimodal examination of daily stress rhythms in chronic Cannabis users. Psychopharmacology. 2024-11-05. PMID:39500774. |
the endocannabinoid system is involved in the neuroendocrine stress response, and diurnal cortisol rhythms may be disrupted in chronic cannabis users. |
2024-11-05 |
2024-11-08 |
Not clear |
| Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, Elaheh Ainy, Roghayeh Kiani, Alireza Zali, MirMohammad Mir. Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 168. 2024-11-04. PMID:39491419. |
cannabidiol (cbd), a cannabinoid that does not create psychoactive activities, has been identified as having a multitude of therapeutic benefits. |
2024-11-04 |
2024-11-06 |
Not clear |
| Natalia Murataeva, Sam Mattox, Josh Lemieux, John Griffis, Kyle Yust, Wenwen Du, Thomas Heinbockel, Alex Straike. Cannabinoid regulation of sex-dependent murine odorant-stimulated salivation. Scientific reports. vol 14. issue 1. 2024-11-04. PMID:39496764. |
cannabis user complaints of dry mouth prompted a study that showed that basal salivation is likely regulated by cannabinoid cb1 receptors on neurons that innervate the submandibular gland. |
2024-11-04 |
2024-11-07 |
mouse |
| Erin Johnson, Michael Kilgore, Paul Nuzzo, Shanna Babaloni. Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Cannabis and cannabinoid research. 2024-10-31. PMID:39478329. |
minor cannabinoid profile of unregulated cannabidiol products. |
2024-10-31 |
2024-11-02 |
Not clear |
| Chittaranjan Andrad. Maternal Cannabis Use During Pregnancy and Maternal and Neonatal Adverse Outcomes. The Journal of clinical psychiatry. vol 85. issue 4. 2024-10-31. PMID:39480147. |
these risks arise from effects of cannabis on cannabinoid receptors in the placenta as well as from cannabis constituents that cross the placenta and act on receptors in the developing fetal brain; other mechanisms may also operate. |
2024-10-31 |
2024-11-02 |
Not clear |
| Jwa Yeong Cho, Da Hye Ryu, Muhammad Hamayun, Su Hyeon Lee, Je Hyeong Jung, Ho-Youn Ki. Scent Knows Better: Utilizing Volatile Organic Compounds as a Robust Tool for Identifying Higher Cannabidiol- and Tetrahydrocannabinol-Containing Cannabis Cultivars in Field Conditions. Journal of agricultural and food chemistry. 2024-10-29. PMID:39468951. |
the primary cannabinoids cannabidiol (cbd) and tetrahydrocannabinol (thc), found in cannabis, are known to originate from genetic diversity, resulting in distinct characteristics. |
2024-10-29 |
2024-10-31 |
Not clear |
| Renée Martin-Willett, Carillon J Skrzynski, Ethan M Taylor, Cristina Sempio, Jost Klawitter, L Cinnamon Bidwel. The Interplay of Exogenous Cannabinoid Use on Anandamide and 2-Arachidonoylglycerol in Anxiety: Results from a Quasi-Experimental Ad Libitum Study. Pharmaceuticals (Basel, Switzerland). vol 17. issue 10. 2024-10-26. PMID:39458976. |
both cannabis use and the endocannabinoid system have been connected with anxiety relief/anxiolytic properties, but these relationships are complex, and the underlying mechanisms for them are unclear. |
2024-10-26 |
2024-10-29 |
Not clear |
| Fernanda da Silva Rodrigues, Jeferson Jantsch, Gabriel de Farias Fraga, Victor Silva Dias, Camila Pereira Medeiros, Fernanda Wickert, Nadja Schroder, Marcia Giovernardi, Renata Padilha Guede. Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring. Neuropharmacology. vol 262. 2024-10-25. PMID:39447736. |
cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring. |
2024-10-25 |
2024-10-28 |
rat |
| Luís Gustavo Ramos de Moraes Calheiros, Giovana Pedro, Thayna Oliveira da Silva, Rogério Martins Amorim, Carlos Eduardo Fonseca Alves, Renée Laufer-Amori. In Vitro Antitumor Effect of Oils Rich in CBD and THC Cannabis Extract in Canine Prostate Carcinoma Cell Lines. Veterinary sciences. vol 11. issue 10. 2024-10-25. PMID:39453093. |
cannabidiol (cbd) and Δ9-tetrahydrocannabinol (thc) are the two main cannabinoids extracted from |
2024-10-25 |
2024-10-28 |
human |
| Heith Copes, Megan Webb, Jessica Valle. Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance. Qualitative health research. 2024-10-25. PMID:39455058. |
contesting cannabinoid hyperemesis syndrome: how narratives of cannabis shape diagnosis contestation and treatment resistance. |
2024-10-25 |
2024-10-29 |
human |
| Heith Copes, Megan Webb, Jessica Valle. Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance. Qualitative health research. 2024-10-25. PMID:39455058. |
cannabinoid hyperemesis syndrome (chs) is characterized by the onset of cyclic bouts of severe nausea and vomiting in chronic cannabis users. |
2024-10-25 |
2024-10-29 |
human |
| Driti Reechaye, Anne Laure Annaick Perrine, Yashil Jahajeeah, Fateema Dookhee, Jared Robinson, Indrajit Banerje. Cannabinoids as a Natural Alternative for the Management of Neuropathic Pain: A Systematic Review of Randomized Placebo-Controlled Trials. Cureus. vol 16. issue 9. 2024-10-24. PMID:39445260. |
recently, cannabinoids have emerged as an alternative and natural option for the treatment of chronic pain, with tetrahydrocannabinol (thc) and cannabidiol (cbd) being the most extensively studied neuroactive components. |
2024-10-24 |
2024-10-26 |
Not clear |
| Steven Didik, Oleg Palygin, Mark Chandy, Alexander Staruschenk. The effects of cannabinoids on the kidney. Acta physiologica (Oxford, England). 2024-10-24. PMID:39445706. |
cannabinoids are a class of drugs derived from the cannabis plant that are widely used for the treatment of various medical conditions and recreational use. |
2024-10-24 |
2024-10-26 |
Not clear |
| Matthew C Nali, Joshua S Yang, Zhuoran Li, Meng Zhen Larsen, Tim K Macke. Cannabis-Derived Product Types, Flavors, and Compound Types From an E-Commerce Website. JAMA network open. vol 7. issue 10. 2024-10-21. PMID:39432307. |
a classification of product and flavor types is necessary to establish a foundation for comparative research, although research aiming to classify cannabis in its variety of products, flavors, and cannabinoid compounds based on public online e-commerce data is lacking. |
2024-10-21 |
2024-10-23 |
Not clear |